Tao Zhang

机构：Sun Yat-sen University, Jilin University, First Hospital of Jilin University, The Affiliated Yongchuan Hospital of Chongqing Medical University, Third Affiliated Hospital of Sun Yat-sen University, Chongqing Medical University, CAE (Canada) · ORCID：0000-0001-6549-3377

发表论文 60 篇 · 总被引 753 次 · h-index 14

代表论文

• Microvesicles-hydrogel breaks the cycle of cellular senescence by improving mitochondrial function to treat osteoarthritis (2023 · Journal of Nanobiotechnology · 被引 58)
• Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study (2022 · European Journal of Cancer · 被引 42)
• Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial (2022 · British Journal of Cancer · 被引 32)
• Association of Exposure to Heavy Metal Mixtures with Systemic Immune-Inflammation Index Among US Adults in NHANES 2011–2016 (2023 · Biological Trace Element Research · 被引 24)
• Efficacy of direct anterior approach versus posterolateral approach in total hip arthroplasty: a systematic review and meta-analysis (2024 · Archives of Orthopaedic and Trauma Surgery · 被引 16)
• Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study. (2021 · Journal of Clinical Oncology · 被引 13)